Male-mediated developmental toxicity in mice after 8 weeks'exposure to low doses of X-rays.

Int J Radiat Biol

Department of Radiation Protection and Radiobiology, National Institute of Hygiene, Warsaw, Poland.

Published: November 2005

Purpose: The aim of the study was to investigate the effects of subchronic irradiation of male mice on reproduction ability and induction of male-mediated teratogenesis.

Materials And Methods: Male mice were irradiated to 0.05 Gy, 0.10 Gy and 0.20 Gy daily for 8 weeks, 5 days per week. The total doses were 2.00 Gy, 4.00 Gy and 8.00 Gy, respectively. After the end of exposure each male was caged with two untreated females. The females were sacrificed on day 17 based on the finding of a vaginal plug. Females were examined for the number of live and dead implantations and the incidence of congenital malformations of survival foetuses.

Results: The fertilization ability of males was not diminished. The exposure to 0.20 Gy daily significantly decreased the percent of pregnant females and the number of total implantations. Exposure to 0.10 Gy and 0.20 Gy daily caused decreases in the number of live foetuses and induced dominant lethal mutations (over 50% at the highest dose). Exposure to each dose significantly enhanced the number of deaths (especially early) implants. The incidence of gross and skeletal malformations was not statistically significant, except for skeletal malformations at the highest dose.

Conclusions: Results confirmed that irradiation of male germ cells cause genetic effects which could be transmitted to the offspring. After subchronic exposure to low doses the majority of mutations caused premature death. Subchronic exposure to low doses of X-rays did not induce external and skeletal malformations of surviving foetuses.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09553000600554275DOI Listing

Publication Analysis

Top Keywords

low doses
12
020 daily
12
skeletal malformations
12
doses x-rays
8
irradiation male
8
male mice
8
010 020
8
number live
8
subchronic exposure
8
exposure low
8

Similar Publications

Assessing fetal radiation dose from iodine-125 seeds in pregnant breast cancer patients: an updated model.

Phys Med Biol

January 2025

Department of Medical Physics, Jeroen Bosch Ziekenhuis, Henri Dunantstraat 1, 's-Hertogenbosch, 5223GZ, NETHERLANDS.

The treatment of breast cancer during pregnancy requires careful consideration of consequences for both maternal and fetal health. In non-pregnant patients, the use of radioactive iodine-125 (125I)-seeds is standard practice for localising non-palpable breast tumors before breast-conserving surgery. However, the use of 125I-seeds in pregnant patients has been avoided due to concerns about fetal radiation exposure.

View Article and Find Full Text PDF

The protein deacetylase HDAC6 has been controversially linked to cancer cell proliferation and viral propagation. We analyzed whether a pharmacological depletion of HDAC6 with a recent proteolysis-targeting chimera (PROTAC) kills tumor cells. We show that low micromolar doses of the cereblon-based PROTAC TH170, but not its inactive analog TH170E, induce proteasomal degradation of HDAC6.

View Article and Find Full Text PDF

Contrast-enhanced mammography (CEM) is growing in clinical use due to its increased sensitivity and specificity compared to full-field digital mammography (FFDM) and/or digital breast tomosynthesis (DBT), particularly in patients with dense breasts. To perform an intraindividual comparison of MGD between FFDM, DBT, a combination protocol using both FFDM and DBT (combined FFDM-DBT), and CEM, in patients undergoing breast cancer screening. This retrospective study included 389 women (median age, 57.

View Article and Find Full Text PDF

Kidney Targeting Smart Antibiotic Discovery: Multimechanism Pleuromutilins for Pyelonephritis Therapy.

J Med Chem

January 2025

Xi'an Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Therapeutics Research, Xi'an 710021, China.

Multidrug-resistant (MDR) bacteria pose a global health threat, underscoring the need for new antibiotics. Lefamulin, the first novel-mechanism antibiotic approved by the FDA in decades, showcases pleuromutilins' promise due to low mutation frequency. However, their clinical use is limited by poor pharmacokinetics and organ toxicity.

View Article and Find Full Text PDF

Objective: To estimate vaccination coverage and analyze factors associated with full vaccination among children up to 15 months old in the city of Natal-RN, Brazil.

Methods: Population-based survey with data recorded on children's vaccination cards and interviews conducted in 2020 and 2021. Analysis of factors associated with complete vaccination was performed by calculating prevalence ratios (PR) and 95% confidence intervals (95%CI) using Poisson regression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!